西藏药业(600211.SH)：公司目前没有明确治疗流感病毒的药

Group 1 - The core viewpoint of the article is that Xizang Pharmaceutical (600211.SH) currently does not have a specific drug for treating influenza virus [1] - The company's product, Xiaor Shuangqing Granules, is a unique national Class III new drug and a Category B product under the national medical insurance [1] - Xiaor Shuangqing Granules is recommended in the "Clinical Application Guidelines for Traditional Chinese Medicine in Treating Acute Upper Respiratory Infections in Children - 2020" [1] Group 2 - The main function of Xiaor Shuangqing Granules is to clear heat and detoxify, addressing both exterior and interior conditions [1] - It is indicated for children with symptoms of exterior heat syndrome, including fever, runny nose, red throat, thirst, dry stools, red urine, red tongue, and yellow coating [1] - The product is used for acute upper respiratory infections presenting the aforementioned symptoms [1]